Joyzyme Group (8622.HK) Stock Price

Joyzyme Group Price

CLOSED
0.15CNY-0.0009 (-0.57 %)
Market closed

Revenue has compounded at 3.0% per year over the past 9 years to 25.36 M CNY. Joyzyme Group's net margin stands at -16.4%, up from -52.9% several years earlier.

Joyzyme Group stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Joyzyme Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Joyzyme Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Joyzyme Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Joyzyme Group Stock Price History
DateJoyzyme Group Price
7/17/20260.15 CNY
7/16/20260.15 CNY
7/15/20260.16 CNY
7/14/20260.15 CNY
7/13/20260.15 CNY
7/10/20260.15 CNY
7/9/20260.15 CNY
7/8/20260.17 CNY
7/7/20260.17 CNY
7/6/20260.17 CNY
7/3/20260.17 CNY
7/2/20260.17 CNY
6/30/20260.17 CNY
6/29/20260.17 CNY
6/26/20260.18 CNY
6/25/20260.18 CNY
6/24/20260.18 CNY
6/23/20260.17 CNY
6/22/20260.17 CNY
6/18/20260.19 CNY
6/17/20260.20 CNY
6/16/20260.19 CNY
6/15/20260.19 CNY
6/12/20260.19 CNY
6/11/20260.19 CNY
6/10/20260.19 CNY
6/9/20260.19 CNY
6/8/20260.19 CNY
6/5/20260.20 CNY
6/4/20260.19 CNY
6/3/20260.19 CNY
6/2/20260.19 CNY
6/1/20260.19 CNY
5/29/20260.19 CNY
5/28/20260.20 CNY
5/27/20260.23 CNY
5/26/20260.24 CNY
5/22/20260.27 CNY
5/21/20260.27 CNY
5/20/20260.28 CNY
5/19/20260.28 CNY
5/18/20260.28 CNY
5/15/20260.28 CNY
5/14/20260.27 CNY
5/13/20260.29 CNY
5/12/20260.29 CNY
5/11/20260.28 CNY
5/8/20260.29 CNY
5/7/20260.28 CNY
5/6/20260.28 CNY
5/5/20260.29 CNY
5/4/20260.29 CNY
4/30/20260.30 CNY
4/29/20260.29 CNY
4/28/20260.28 CNY
4/27/20260.29 CNY
4/24/20260.28 CNY
4/23/20260.28 CNY
4/22/20260.29 CNY
4/21/20260.30 CNY
4/20/20260.29 CNY
4/17/20260.29 CNY
4/16/20260.28 CNY
4/15/20260.29 CNY
4/14/20260.30 CNY
4/13/20260.28 CNY
4/10/20260.28 CNY
4/9/20260.28 CNY
4/8/20260.30 CNY
4/2/20260.30 CNY
4/1/20260.28 CNY
3/31/20260.26 CNY
3/30/20260.28 CNY
3/27/20260.27 CNY
3/26/20260.26 CNY
3/25/20260.27 CNY
3/24/20260.27 CNY
3/23/20260.27 CNY
3/20/20260.27 CNY
3/19/20260.27 CNY
3/18/20260.27 CNY
3/17/20260.27 CNY
3/16/20260.27 CNY
3/13/20260.30 CNY
3/12/20260.30 CNY
3/11/20260.30 CNY
3/10/20260.30 CNY
3/9/20260.30 CNY
3/6/20260.31 CNY
3/5/20260.30 CNY
3/4/20260.30 CNY
3/3/20260.30 CNY
3/2/20260.30 CNY
2/27/20260.30 CNY
2/26/20260.30 CNY
2/25/20260.30 CNY
2/24/20260.30 CNY
2/23/20260.30 CNY
2/20/20260.30 CNY
2/16/20260.31 CNY
2/13/20260.31 CNY
2/12/20260.31 CNY
2/11/20260.33 CNY
2/10/20260.31 CNY
2/9/20260.33 CNY
2/6/20260.33 CNY
2/5/20260.33 CNY
2/4/20260.33 CNY
2/3/20260.32 CNY
2/2/20260.33 CNY
1/30/20260.34 CNY
1/29/20260.33 CNY
1/28/20260.34 CNY
1/27/20260.34 CNY
1/26/20260.34 CNY
1/23/20260.35 CNY
1/22/20260.35 CNY
1/21/20260.35 CNY
1/20/20260.35 CNY
1/19/20260.37 CNY
1/16/20260.37 CNY
1/15/20260.36 CNY
1/14/20260.37 CNY
1/13/20260.36 CNY
1/12/20260.36 CNY
1/9/20260.36 CNY
1/8/20260.36 CNY
1/7/20260.36 CNY
1/6/20260.36 CNY
1/5/20260.36 CNY
1/2/20260.37 CNY
12/31/20250.38 CNY
12/30/20250.35 CNY
12/29/20250.34 CNY
12/24/20250.36 CNY
12/23/20250.35 CNY
12/22/20250.35 CNY
12/19/20250.37 CNY
12/18/20250.37 CNY
12/17/20250.37 CNY
12/16/20250.37 CNY
12/15/20250.34 CNY
12/12/20250.33 CNY
12/11/20250.33 CNY
12/10/20250.37 CNY
12/9/20250.35 CNY
12/8/20250.33 CNY
12/5/20250.34 CNY
12/4/20250.43 CNY
12/3/20250.42 CNY
12/2/20250.40 CNY
12/1/20250.36 CNY
11/28/20250.36 CNY
11/27/20250.33 CNY
11/26/20250.31 CNY
11/25/20250.30 CNY
11/24/20250.31 CNY
11/21/20250.44 CNY
11/20/20250.49 CNY
11/19/20250.46 CNY
11/18/20250.47 CNY
11/17/20250.47 CNY
11/14/20250.47 CNY
11/13/20250.48 CNY
11/12/20250.48 CNY
11/11/20250.52 CNY
11/10/20250.50 CNY
11/7/20250.45 CNY
11/6/20250.43 CNY
11/5/20250.43 CNY
11/4/20250.48 CNY
11/3/20250.41 CNY
10/31/20250.48 CNY
10/30/20250.61 CNY
10/28/20250.56 CNY
10/27/20250.51 CNY
10/24/20250.46 CNY
10/23/20250.45 CNY
10/22/20250.47 CNY
10/21/20250.40 CNY
10/20/20250.37 CNY
10/17/20250.37 CNY
10/16/20250.37 CNY
10/15/20250.37 CNY
10/14/20250.36 CNY
10/13/20250.37 CNY
10/10/20250.37 CNY
10/9/20250.34 CNY
10/8/20250.34 CNY
10/6/20250.34 CNY
10/3/20250.34 CNY
10/2/20250.35 CNY
9/30/20250.35 CNY
9/29/20250.34 CNY
9/26/20250.34 CNY
9/25/20250.35 CNY
9/24/20250.35 CNY
9/23/20250.34 CNY
9/22/20250.35 CNY
9/19/20250.34 CNY
9/18/20250.35 CNY
9/17/20250.34 CNY
9/16/20250.34 CNY
9/15/20250.34 CNY
9/12/20250.35 CNY
9/11/20250.35 CNY
9/10/20250.35 CNY
9/9/20250.35 CNY
9/8/20250.35 CNY
9/5/20250.34 CNY
9/4/20250.35 CNY
9/3/20250.36 CNY
9/2/20250.36 CNY
9/1/20250.35 CNY
8/29/20250.34 CNY
8/28/20250.33 CNY
8/27/20250.33 CNY
8/26/20250.33 CNY
8/25/20250.33 CNY
8/22/20250.33 CNY
8/21/20250.33 CNY
8/20/20250.33 CNY
8/19/20250.33 CNY
8/18/20250.33 CNY
8/15/20250.33 CNY
8/14/20250.33 CNY
8/13/20250.33 CNY
8/12/20250.33 CNY
8/11/20250.33 CNY
8/8/20250.33 CNY
8/7/20250.35 CNY
8/6/20250.34 CNY
8/5/20250.33 CNY
8/4/20250.32 CNY
8/1/20250.33 CNY
7/31/20250.32 CNY
7/30/20250.32 CNY
7/29/20250.31 CNY
7/28/20250.31 CNY
7/25/20250.31 CNY
7/24/20250.30 CNY
7/23/20250.30 CNY
7/22/20250.31 CNY
7/21/20250.31 CNY
Access this data via the Eulerpool API
Get Free API Key

Joyzyme Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
26.54 M CNY
11.92 M CNY
-1.95 M CNY
Jan 1, 2018
28.68 M CNY
9.15 M CNY
-459,000.00 CNY
Jan 1, 2019
25.47 M CNY
48,000.00 CNY
-284,000.00 CNY
Jan 1, 2020
21.97 M CNY
-7.83 M CNY
-11.63 M CNY
Jan 1, 2021
26.13 M CNY
-3.72 M CNY
-4.22 M CNY
Jan 1, 2022
25.33 M CNY
-4.21 M CNY
-3.08 M CNY
Jan 1, 2023
24.63 M CNY
-6.38 M CNY
-5.78 M CNY
Jan 1, 2024
25.36 M CNY
-4.83 M CNY
-4.16 M CNY

Joyzyme Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 20, 2026, 10:49 PM
 
REVENUEM CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM CNY
EBITM CNY
EBIT MARGIN%
NET INCOMEM CNY
NET INCOME GROWTH%
SHARESM
2015201620172018201920202021202220232024
19.0025.0026.0028.0025.0021.0026.0025.0024.0025.00
–31.584.007.69-10.71-16.0023.81-3.85-4.004.17
73.6868.0069.2375.0068.0066.6761.5464.0062.5068.00
14.0017.0018.0021.0017.0014.0016.0016.0015.0017.00
10.0011.0011.009.00–-7.00-3.00-4.00-6.00-4.00
52.6344.0042.3132.14–-33.33-11.54-16.00-25.00-16.00
7.008.00-1.00––-11.00-4.00-3.00-5.00-4.00
–14.29-112.50–––-63.64-25.0066.67-20.00
240.00240.00260.22305.21400.00400.00400.00404.64415.96482.44
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Joyzyme Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Joyzyme Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Joyzyme Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Joyzyme Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Joyzyme Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Joyzyme Group stock margins

The Joyzyme Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Joyzyme Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Joyzyme Group.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
69.83 %
44.90 %
-7.35 %
Jan 1, 2018
75.25 %
31.91 %
-1.60 %
Jan 1, 2019
70.24 %
0.19 %
-1.11 %
Jan 1, 2020
67.00 %
-35.62 %
-52.93 %
Jan 1, 2021
62.98 %
-14.24 %
-16.15 %
Jan 1, 2022
66.77 %
-16.64 %
-12.14 %
Jan 1, 2023
64.49 %
-25.92 %
-23.48 %
Jan 1, 2024
67.32 %
-19.03 %
-16.40 %

Joyzyme Group Stock Revenue, EBIT, Earnings per Share

The Joyzyme Group earnings per share therefore indicates how much revenue Joyzyme Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
0.10 CNY
0.05 CNY
-0.01 CNY
Jan 1, 2018
0.09 CNY
0.03 CNY
-0.00 CNY
Jan 1, 2019
0.06 CNY
0.00 CNY
-0.00 CNY
Jan 1, 2020
0.05 CNY
-0.02 CNY
-0.03 CNY
Jan 1, 2021
0.07 CNY
-0.01 CNY
-0.01 CNY
Jan 1, 2022
0.06 CNY
-0.01 CNY
-0.01 CNY
Jan 1, 2023
0.06 CNY
-0.02 CNY
-0.01 CNY
Jan 1, 2024
0.05 CNY
-0.01 CNY
-0.01 CNY

Joyzyme Group business model & stock analysis

Huakang Biomedical Holdings Co Ltd is a leading company in the field of biomedical research and development. It was founded in 2004 and is headquartered in Shenzhen, China. The company is listed on the Hong Kong Stock Exchange (HKEX: 8622) and has branches in various countries, including Germany and the USA. Answer: Huakang Biomedical Holdings Co Ltd is a leading company in the field of biomedical research and development. It was founded in 2004 and is headquartered in Shenzhen, China. The company is listed on the Hong Kong Stock Exchange (HKEX: 8622) and has branches in various countries, including Germany and the USA.

Joyzyme Group SWOT Analysis

Strengths

Huakang Biomedical Holdings Co Ltd possesses several strengths that contribute to its competitive advantage:

  • Strong market presence and brand recognition
  • Extensive product portfolio with a focus on healthcare solutions
  • Advanced technology and innovation capabilities
  • Robust distribution network and strategic partnerships
  • Established customer base and loyal clients

Weaknesses

Despite its strengths, Huakang Biomedical Holdings Co Ltd also faces certain weaknesses that may hinder its growth:

  • Dependence on a limited number of key suppliers
  • Relatively high production costs compared to competitors
  • Limited geographical presence and market penetration
  • Regulatory challenges and compliance requirements

Opportunities

There are several opportunities that Huakang Biomedical Holdings Co Ltd can explore to expand its business:

  • Emerging markets with growing demand for healthcare solutions
  • Technological advancements and research in the healthcare industry
  • Partnerships and collaborations with other key players
  • Increasing focus on preventive healthcare and wellness
  • Expanding product portfolio to cater to diverse customer needs

Threats

Huakang Biomedical Holdings Co Ltd should be aware of the following threats that may impact its operations:

  • Intense competition from established and emerging competitors
  • Economic fluctuations and market uncertainties
  • Changing regulatory and compliance landscape
  • Rapid technological changes and potential disruption
  • Supply chain disruptions and raw material availability

Joyzyme Group Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Joyzyme Group historical P/E ratio, EBIT multiple, and P/S ratio

Joyzyme Group annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Joyzyme Group shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
260.22 M Stocks
Jan 1, 2018
305.21 M Stocks
Jan 1, 2019
400.00 M Stocks
Jan 1, 2020
400.00 M Stocks
Jan 1, 2021
400.00 M Stocks
Jan 1, 2022
404.64 M Stocks
Jan 1, 2023
415.96 M Stocks
Jan 1, 2024
482.44 M Stocks
Price targets and forecasts for Joyzyme Group are not yet available.

Joyzyme Group shareholder structure

% Name
28.74410%
Li (King Yeung)
Li (King Yeung)
25.02962%
Yu (Chi Mau)
Yu (Chi Mau)
0.82912%
Poon (Lai Yin Michael)
Poon (Lai Yin Michael)
0.00000%
Zhang (Shuguang)
Zhang (Shuguang)
0.00000%
Chang (Yim Yang)
Chang (Yim Yang)
0.00000%
Lau (Lai Yee)
Lau (Lai Yee)

Joyzyme Group Executives and Management Board

LP

Mr. Lai Yin Poon

(50)

Chief Financial Officer, Compliance Officer, Executive Director · since 2017

Compensation1.03 M CNY
JH

Mr. Jiaming He

(36)

Executive Director

Compensation445,000.00 CNY
CZ

Mr. Chunguang Zhang

(54)

Chief Executive Officer, Executive Director · since 2017

Compensation399,000.00 CNY
SZ

Mr. Shuguang Zhang

(51)

Executive Chairman of the Board · since 2017

Compensation333,000.00 CNY
FC

Dr. Faat Ting Cheng

(54)

Independent Non-Executive Director

Compensation83,000.00 CNY

Frequently asked questions about Joyzyme Group

The business model of Huakang Biomedical Holdings Co Ltd revolves around the development, production, and distribution of pharmaceutical products and medical devices. As a company, Huakang focuses on the research and innovation of medical technology, aiming to improve the quality of healthcare for individuals worldwide. They engage in the manufacturing and sale of a diverse range of products, including diagnostic test kits, gene diagnostics, and more. By leveraging their expertise and strategic partnerships, Huakang Biomedical Holdings Co Ltd aims to contribute to the advancement of modern medicine and to improve the well-being of patients globally.

All fundamentals and in-depth analysis of Joyzyme Group

Our stock analysis for Joyzyme Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Joyzyme Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Joyzyme Group Stock
Joyzyme Group Revenue→
Joyzyme Group Stock
Joyzyme Group Net Income→
Joyzyme Group Stock
Joyzyme Group P/E→
Joyzyme Group Stock
Joyzyme Group P/S→
Joyzyme Group Stock
Joyzyme Group EBIT→
Joyzyme Group Stock
Joyzyme Group Dividend→
Joyzyme Group Stock
Joyzyme Group Directors Dealings→
Joyzyme Group Stock
Joyzyme Group Stocks→
Joyzyme Group Stock
Joyzyme Group Market capitalization→
Joyzyme Group Stock
Joyzyme Group Debt→
Joyzyme Group Stock
Joyzyme Group Liabilities→
Joyzyme Group Stock
Joyzyme Group Equity→
Joyzyme Group Stock
Joyzyme Group AAQS→
Joyzyme Group Stock
Joyzyme Group Employees→
Joyzyme Group Stock
Joyzyme Group ROE→
Joyzyme Group Stock
Joyzyme Group ROA→
Joyzyme Group Stock
Joyzyme Group ROCE→
Joyzyme Group Stock
Joyzyme Group News→
Joyzyme Group Stock
Joyzyme Group Analyst Price Targets→

Health Stocks

JS LinkJourney MedicalJTECJointown Pharmaceutical Group CoJubilant PharmovaJointJupiter Life Line HospitalsJoinn Laboratories China CoJupiter NeurosciencesJoincare Pharmaceutical Group Industry CoJW (Cayman) Therapeutics CoJohnson Chemical Pharmaceutical Works CoAll Stocks A–Z →